Accession Number:

AD1034127

Title:

Recommendations Regarding the Department of Defense Routine Smallpox and Anthrax Immunizations Policies

Descriptive Note:

Technical Report

Corporate Author:

DEFENSE HEALTH BOARD FALLS CHURCH VA FALLS CHURCH United States

Personal Author(s):

Report Date:

2010-12-15

Pagination or Media Count:

6.0

Abstract:

The Department of Defense DoD Directive 6205.3, DoD Immunization Program for Biological Warfare Defense, instructs the Defense Health Board DHB to recommend appropriate immunization protocols to the Department and identify vaccines available to protect against biological threat agents.2. The DHB Infectious Disease Control Subcommittee formed a Vaccine Safety and Effectiveness Workgroup within its membership to examine the following a. Operationally significant infectious disease surveillance data. b. Data from DoD researchers evaluating the safety and effectiveness of vaccines currently in use by DoD. c. Future vaccine safety, effectiveness, and disease surveillance studies in DoD. The DHB Vaccine Safety and Effectiveness Workgroup met on September 17, 2009, June 9, 2010, and July 14, 2010 and received briefings on smallpox and anthrax vaccines from the Military Vaccine Agency MIL VAX, U.S. Army Medical Research Institute of Infectious Diseases USAMRIID, the Naval Health Research Center NHRC, and the Vaccine Healthcare Centers VHC Network. On June 9, 2010, the Infectious Disease Subcommittee also received briefings from the Joint Staff and Department of Homeland Security DHS on the Chairmans Biological Agent Threat List and corresponding DHS domestic threat list. Among the issues examined were determining which infectious agents pose a continued threat, the availability of alternative countermeasures, as well as vaccine-associated adverse events and safety data.

Subject Categories:

  • Chemical, Biological and Radiological Warfare
  • Medicine and Medical Research
  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE